Cargando…

Fatigue in Post-COVID-19 Syndrome: Clinical Phenomenology, Comorbidities and Association With Initial Course of COVID-19

INTRODUCTION: Post-COVID-19 syndrome affects approximately 10-25% of people suffering from COVID-19 infection, irrespective of initial COVID-19 severity. Fatigue is one of the major symptoms, occurring in 30-90% of people with post-COVID-19 syndrome. This study aims at describing factors associated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Diem, Lara, Fregolente-Gomes, Livia, Warncke, Jan D., Hammer, Helly, Friedli, Christoph, Kamber, Nicole, Jung, Simon, Bigi, Sandra, Funke-Chambour, Manuela, Chan, Andrew, Bassetti, Claudio L., Salmen, Anke, Hoepner, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9130865/ https://www.ncbi.nlm.nih.gov/pubmed/35633835 http://dx.doi.org/10.1177/11795735221102727

Ejemplares similares

Multidimensional phenotyping of the post‐COVID‐19 syndrome: A Swiss survey study
por: Diem, Lara, et al.
Publicado: (2022)

Post-COVID syndrome: Objective sleep-wake changes in patients with fatigue and excessive daytime sleepiness
por: Fregolente, L.G., et al.
Publicado: (2022)

Negative SARS-CoV2-antibodies after positive COVID-19-PCR nasopharyngeal swab in patients treated with anti-CD20 therapies
por: Friedli, Christoph, et al.
Publicado: (2021)

Application of the “risk of ambulatory disability” (RoAD) score in a “real‐world” single‐center multiple sclerosis cohort
por: Pistor, Maximilian, et al.
Publicado: (2022)

Comparison of mRNA Vaccinations with BNT162b2 or mRNA-1273 in Anti-CD20-Treated Multiple Sclerosis Patients
por: Hammer, Helly, et al.
Publicado: (2022)

Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge
por: Diem, Lara, et al.
Publicado: (2021)

Is COVID‐19 severity associated with reduction in T lymphocytes in anti‐CD20‐treated people with Multiple Sclerosis or Neuromyelitis Optica Spectrum Disorder?
por: Hoepner, Robert, et al.
Publicado: (2022)

Socioeconomic and Regional Disparities in Industry-Sponsored Clinical Trials in Multiple Sclerosis
por: Marti, Stefanie, et al.
Publicado: (2023)

Multiple Sclerosis immunotherapies and COVID-19 mortality: an analysis of the FDA Adverse Event Reporting System
por: Pistor, Maximilian, et al.
Publicado: (2022)

Immunotherapies and COVID-19 mortality: a multidisciplinary open data analysis based on FDA’s Adverse Event Reporting System
por: Pistor, Maximilian, et al.
Publicado: (2021)

Time course of lymphocyte repopulation after dimethyl fumarate-induced grade 3 lymphopenia: contribution of patient age
por: Briner, Myriam, et al.
Publicado: (2019)

Evaluation of diagnostic criteria and red flags of myelin oligodendrocyte glycoprotein encephalomyelitis in a clinical routine cohort
por: Veselaj, Krenar, et al.
Publicado: (2020)

Predicting conversion to multiple sclerosis in patients with radiologically isolated syndrome: a retrospective study
por: Chaloulos-Iakovidis, Panagiotis, et al.
Publicado: (2021)

Multiple sclerosis as a model to investigate SARS‐CoV‐2 effect on brain atrophy
por: Rebsamen, Michael, et al.
Publicado: (2022)

Reduced serum immunoglobulin G concentrations in multiple sclerosis: prevalence and association with disease-modifying therapy and disease course
por: Zoehner, Greta, et al.
Publicado: (2019)

The impact of immunotherapies on COVID-19 case fatality rates during the US vaccination campaign: a multidisciplinary open data analysis using FDA Adverse Event Reporting System and Our World in Data
por: Salmen, Anke, et al.
Publicado: (2023)

Imaging in the aftermath of COVID-19: what to expect
por: Ebner, Lukas, et al.
Publicado: (2020)

Prediction of conversion to multiple sclerosis using the 2017 McDonald and 2016 MAGNIMS criteria in patients with clinically isolated syndrome: a retrospective single-centre study
por: Miclea, Andrei, et al.
Publicado: (2019)

Pathological cerebrospinal fluid protein concentration and albumin quotient at relapse predicts short-term disability progression in multiple sclerosis: a retrospective single center observational study
por: Diem, Lara, et al.
Publicado: (2020)

Reply to: Pharmacotherapy for lung cancer with comorbid interstitial pneumonia: limited evidence requires appropriate evaluation
por: Funke-Chambour, Manuela, et al.
Publicado: (2022)

Registries for Idiopathic Pulmonary Fibrosis: When Is It Time to Go Global?
por: Funke-Chambour, Manuela
Publicado: (2020)

Feelings of loneliness, COVID-19-specific-health anxiety and depressive symptoms during the first COVID-19 wave in Swiss persons with multiple sclerosis
por: Hoepner, Robert, et al.
Publicado: (2022)

Novel insights in cough and breathing patterns of patients with idiopathic pulmonary fibrosis performing repeated 24-hour-respiratory polygraphies
por: Schertel, Anke, et al.
Publicado: (2017)

Circulating calprotectin levels four months after severe and non-severe COVID-19
por: Abu Hussein, N., et al.
Publicado: (2023)

Patterns of Comorbidity and In-Hospital Mortality in Older Patients With COVID-19 Infection
por: Mahmoud, Mona, et al.
Publicado: (2021)

Rebound After Fingolimod and a Single Daclizumab Injection in a Patient Retrospectively Diagnosed With NMO Spectrum Disorder—MRI Apparent Diffusion Coefficient Maps in Differential Diagnosis of Demyelinating CNS Disorders
por: Wagner, Franca, et al.
Publicado: (2018)

Reliable brain morphometry from contrast‐enhanced T1w‐MRI in patients with multiple sclerosis
por: Rebsamen, Michael, et al.
Publicado: (2022)

Comorbidities and COVID-19
por: Yaddanapudi, Lakshmi Narayana
Publicado: (2020)

Human-Based Advanced in vitro Approaches to Investigate Lung Fibrosis and Pulmonary Effects of COVID-19
por: Kiener, Mirjam, et al.
Publicado: (2021)

COVID-19 Fatigue
Publicado: (2021)

Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis
por: Hoepner, Robert, et al.
Publicado: (2014)

Phenomenological reflections on grief during the COVID-19 pandemic
por: Ratcliffe, Matthew
Publicado: (2022)

Alarmins, COVID-19 and comorbidities
por: Di Salvo, Eleonora, et al.
Publicado: (2021)

Comorbidities of COVID-19 Patients
por: Silaghi-Dumitrescu, Radu, et al.
Publicado: (2023)

Fatigue in the COVID-19 pandemic
por: Azzolino, Domenico, et al.
Publicado: (2022)

Dimethyl fumarate vs fingolimod following different pretreatments: A retrospective study
por: Diem, Lara, et al.
Publicado: (2020)

Nurses and Stigma at the Time of COVID-19: A Phenomenological Study
por: Simeone, Silvio, et al.
Publicado: (2021)

The Experience of Patients with COVID-19 in China: An Interpretative Phenomenological Analysis
por: Wang, Yanbo, et al.
Publicado: (2021)

Lived Experiences of the Patients with COVID-19: A Hermeneutic Phenomenology
por: Firouzkouhi, Mohammadreza, et al.
Publicado: (2022)

Mother's Experience with COVID-19 in Breastfeeding: A Phenomenological Study
por: Mufdlilah, Mufdlilah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_h5efjcdhjph0lgl06a78990i27